Clinical Trials Logo

Communicable Diseases clinical trials

View clinical trials related to Communicable Diseases.

Filter by:

NCT ID: NCT01059565 Completed - Cystic Fibrosis Clinical Trials

Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis and Chronic Burkholderia Species Infection

Start date: February 2010
Phase: Phase 3
Study type: Interventional

The purpose of this research study was to determine if an experimental drug called Aztreonam for Inhalation Solution (AZLI) was safe and effective to treat Burkholderia lung infections in patients with cystic fibrosis (CF). Spirometry was used to assess pulmonary function, and the revised Cystic Fibrosis Questionnaire (CFQ-R) was used to assess quality of life. The CFQ-R is a validated, patient-reported outcome tool used to measure health-related quality of life for children and adults with CF. The study consisted of a 24-week randomized phase, and a 24-week open-label phase. Primary and secondary efficacy analyses were conducted for the 24-week randomized phase only. Safety data were collected for both the randomized and open-label phases.

NCT ID: NCT01057771 Completed - Clinical trials for Acute Respiratory Infection

Meditation and Exercise for Prevention of Acute Respiratory Infection

MEPARI
Start date: June 2009
Phase: Phase 2/Phase 3
Study type: Interventional

The overarching goal of this project is to determine whether mind-body practices such as meditation or exercise can reduce the public health burden of acute respiratory infection. A major secondary goal is to determine whether mindfulness meditation or moderately strenuous exercise can enhance immune processes such as antibody response to influenza vaccination (flu shots). Finally, we want to investigate the influence of stress, optimism, anxiety and positive and negative emotion on immunity and resistance to respiratory infection.

NCT ID: NCT01055847 Completed - Cystic Fibrosis Clinical Trials

Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection

Start date: June 2003
Phase: Phase 2
Study type: Interventional

This is multicenter placebo-controlled study evaluating the safety and efficacy of AI at two dosage levels compared to placebo in CF patients with P. aeruginosa lung infection.

NCT ID: NCT01054690 Completed - Clinical trials for Urinary Tract Infection

Silver Alloyed Urinary Catheters and Incidence of Catheter Acquired Urinary Tract Infections (UTI)

Start date: October 2008
Phase: N/A
Study type: Interventional

This study is a single blinded (Outcome Assessors), multicenter randomized controlled study designed to investigate if a silver alloyed urinary catheter with antibacterial properties can reduce the incidence of catheter acquired urinary tract infections in patients undergoing elective surgery. Patients requiring urinary catheterization will be randomized into two groups and receive either the silver alloyed catheter (test) or a silicone catheter (control).

NCT ID: NCT01054677 Completed - Clinical trials for Urinary Tract Infections

Swedish Antibiotic Nursing Home Trial

SANT
Start date: n/a
Phase: N/A
Study type: Interventional

Main aim and objective The aim was to present the treatment of infectious diseases in elderly, especially in nursing homes and further to evaluate the effect of an intervention package aiming at improving treatment with antibiotics in Swedish nursing homes Specific objectives - Present the treatment patterns regarding infectious diseases, including gender aspects in elderly, especially in nursing homes. - Through focus group discussions elucidate the decision making process in nursing homes and target the intervention. - Based on the above information develop an educational intervention to contribute to the improvement of the prescribing of antibiotics in nursing homes - Evaluate the effect of the intervention on quality of prescribing, knowledge and attitudes in relation to available guidelines

NCT ID: NCT01054638 Completed - Clinical trials for Cardiovascular Disease

HIV Treatment and CVD Events

Start date: March 2009
Phase: N/A
Study type: Observational

Cardiovascular disease (CVD) has been associated with HIV infection. However, it is uncertain whether increased CVD rates are associated with HIV-related factors (e.g., HIV-infection or highly active antiretroviral therapy (HAART) may worsen dyslipidemia) or reflect differences in the prevalence of underlying risk factors for CVD. Furthermore, the association between initiation and duration of HAART exposure and CVD risk, including which specific drugs within the HAART classes may contribute to the increased risk, is unknown. The primary objectives of the study are therefore: 1. To estimate the absolute and relative incidence rate (IR) of CVD claims-based diagnoses among a cohort of adult patients from a large managed care population with a claims diagnosis of HIV, AIDS, or AIDS-related complex (ARC) during periods of exposure to: - Any HAART compared to no HAART exposure - HAART class [i.e., NRTIs, NNRTIs, PIs, and Other (i.e., fusion inhibitors)] compared to no HAART class exposure - Specific NRTI medications compared to no specific NRTI exposure

NCT ID: NCT01050465 Completed - Obesity Clinical Trials

MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use

Start date: May 2009
Phase: N/A
Study type: Interventional

The specific aim of this proposed pilot study is to compare two standardized processes (paper and electronic) to deliver a customized MedlinePlus health information prescription.

NCT ID: NCT01049971 Completed - Colorectal Surgery Clinical Trials

REDWIL: Reduction of Wound Infections in Laparoscopic Colon Resections by Wound Protectors

REDWIL
Start date: December 2007
Phase: N/A
Study type: Interventional

Surgical site infection is common in colorectal surgery leading to increased postoperative pain, longer hospital stay, delayed wound healing and increased re-operation rates. Hence, reducing the wound infection rate is a major aim in abdominal surgery. Wound protectors were invented for retracting the abdominal wall and keeping the abdominal wall sterile in order to reduce bacterial colonialization of the wound and wound infections. This is a prospective-randomized trial comparing use of wound protectors versus woven drapes in laparoscopic colon resections with minilaparotomy.

NCT ID: NCT01049438 Completed - Clinical trials for Methicillin Resistant Staphylococcus Aureus Skin Infections

A Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections

Start date: August 2006
Phase: N/A
Study type: Interventional

This clinical trial tests the hypothesis that body decolonization of patients with recurrent community-associated (CA) MRSA infections will significantly reduce the likelihood of recurrent CA-MRSA infection.

NCT ID: NCT01043809 Completed - Infectious Disease Clinical Trials

Evaluation of a Handwashing Promotion Program in Three Countries

Start date: January 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to assess whether simple, school-based handwashing promotion impacts health and hygiene knowledge among students and their families.